Interaction between flurbiprofen and indomethacin in rheumatoid arthritis
The aim of this study was to measure serum levels of flurbiprofen and indomethacin when administered alone or in combination. Changes in clinical effect and toxicity were also noted. Ten patients with classical or definite rheumatoid arthritis (RA) according to the American Rheumatism Association�...
Gespeichert in:
| Veröffentlicht in: | British journal of clinical pharmacology 1982-03, Vol.13 (3), p.448-451 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 451 |
|---|---|
| container_issue | 3 |
| container_start_page | 448 |
| container_title | British journal of clinical pharmacology |
| container_volume | 13 |
| creator | Rudge, SR Lloyd‐Jones, JK Hind, ID |
| description | The aim of this study was to measure serum levels of flurbiprofen and indomethacin when administered alone or in combination. Changes in clinical effect and toxicity were also noted. Ten patients with classical or definite rheumatoid arthritis (RA) according to the American Rheumatism Association's criteria agreed to take part in the study, which was approved by the Hospital Ethical Committee. All were female with ages ranging from 29-64 years (median 55 years) and a disease duration from 6 months-22 years (median 5 years). |
| doi_str_mv | 10.1111/j.1365-2125.1982.tb01401.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1402125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15510393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5081-215b201345f9542dcaebff7b51f3bf5cc80f730b58ab759a58e574bea83fb793</originalsourceid><addsrcrecordid>eNqVUU1rGzEQFaUldZP8hMKSQ2_eSiuPdzeHhNb0wxBIDrkLSTuqZXYlR9Lm499Xi41JjhECzfBmnh7vEXLBaMny-b4tGV_CvGIVlKxtqjIpyhaUlc8fyOwIfSQzyulyDhWwz-RLjFtKGWdLOCEnNeX5VjOyXruEQepkvSsUpidEV5h-DMrugje5ka4rrOv8gGkjtXW5KcIGx0Emb7tChrQJNtl4Rj4Z2Uc8P7yn5P73r_vV3_nN7Z_16sfNXANtWFYGqso6FmBaWFSdlqiMqRUww5UBrRtqak4VNFLV0EpoEOqFQtlwo-qWn5KrPe1uVAN2Gl0Kshe7YAcZXoSXVrxFnN2If_5RZIMmVzLBtwNB8A8jxiQGGzX2vXToxygYAKO85Xnwcj-og48xoDl-wqiYchBbMZktJlox5SAOOYjnvPz1tczj6sH4jF_v8Sfb48s7mMXP1d1U8f87jprT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15510393</pqid></control><display><type>article</type><title>Interaction between flurbiprofen and indomethacin in rheumatoid arthritis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rudge, SR ; Lloyd‐Jones, JK ; Hind, ID</creator><creatorcontrib>Rudge, SR ; Lloyd‐Jones, JK ; Hind, ID</creatorcontrib><description>The aim of this study was to measure serum levels of flurbiprofen and indomethacin when administered alone or in combination. Changes in clinical effect and toxicity were also noted. Ten patients with classical or definite rheumatoid arthritis (RA) according to the American Rheumatism Association's criteria agreed to take part in the study, which was approved by the Hospital Ethical Committee. All were female with ages ranging from 29-64 years (median 55 years) and a disease duration from 6 months-22 years (median 5 years).</description><identifier>ISSN: 0306-5251</identifier><identifier>EISSN: 1365-2125</identifier><identifier>DOI: 10.1111/j.1365-2125.1982.tb01401.x</identifier><identifier>PMID: 7037032</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Arthritis, Rheumatoid - drug therapy ; Child ; Child, Preschool ; Clinical Trials as Topic ; Double-Blind Method ; Drug Interactions ; Female ; Flurbiprofen - blood ; Flurbiprofen - therapeutic use ; Humans ; Indomethacin - blood ; Indomethacin - therapeutic use ; Infant ; Propionates - therapeutic use</subject><ispartof>British journal of clinical pharmacology, 1982-03, Vol.13 (3), p.448-451</ispartof><rights>1982 The British Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5081-215b201345f9542dcaebff7b51f3bf5cc80f730b58ab759a58e574bea83fb793</citedby><cites>FETCH-LOGICAL-c5081-215b201345f9542dcaebff7b51f3bf5cc80f730b58ab759a58e574bea83fb793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7037032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rudge, SR</creatorcontrib><creatorcontrib>Lloyd‐Jones, JK</creatorcontrib><creatorcontrib>Hind, ID</creatorcontrib><title>Interaction between flurbiprofen and indomethacin in rheumatoid arthritis</title><title>British journal of clinical pharmacology</title><addtitle>Br J Clin Pharmacol</addtitle><description>The aim of this study was to measure serum levels of flurbiprofen and indomethacin when administered alone or in combination. Changes in clinical effect and toxicity were also noted. Ten patients with classical or definite rheumatoid arthritis (RA) according to the American Rheumatism Association's criteria agreed to take part in the study, which was approved by the Hospital Ethical Committee. All were female with ages ranging from 29-64 years (median 55 years) and a disease duration from 6 months-22 years (median 5 years).</description><subject>Adolescent</subject><subject>Adult</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Trials as Topic</subject><subject>Double-Blind Method</subject><subject>Drug Interactions</subject><subject>Female</subject><subject>Flurbiprofen - blood</subject><subject>Flurbiprofen - therapeutic use</subject><subject>Humans</subject><subject>Indomethacin - blood</subject><subject>Indomethacin - therapeutic use</subject><subject>Infant</subject><subject>Propionates - therapeutic use</subject><issn>0306-5251</issn><issn>1365-2125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUU1rGzEQFaUldZP8hMKSQ2_eSiuPdzeHhNb0wxBIDrkLSTuqZXYlR9Lm499Xi41JjhECzfBmnh7vEXLBaMny-b4tGV_CvGIVlKxtqjIpyhaUlc8fyOwIfSQzyulyDhWwz-RLjFtKGWdLOCEnNeX5VjOyXruEQepkvSsUpidEV5h-DMrugje5ka4rrOv8gGkjtXW5KcIGx0Emb7tChrQJNtl4Rj4Z2Uc8P7yn5P73r_vV3_nN7Z_16sfNXANtWFYGqso6FmBaWFSdlqiMqRUww5UBrRtqak4VNFLV0EpoEOqFQtlwo-qWn5KrPe1uVAN2Gl0Kshe7YAcZXoSXVrxFnN2If_5RZIMmVzLBtwNB8A8jxiQGGzX2vXToxygYAKO85Xnwcj-og48xoDl-wqiYchBbMZktJlox5SAOOYjnvPz1tczj6sH4jF_v8Sfb48s7mMXP1d1U8f87jprT</recordid><startdate>198203</startdate><enddate>198203</enddate><creator>Rudge, SR</creator><creator>Lloyd‐Jones, JK</creator><creator>Hind, ID</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>198203</creationdate><title>Interaction between flurbiprofen and indomethacin in rheumatoid arthritis</title><author>Rudge, SR ; Lloyd‐Jones, JK ; Hind, ID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5081-215b201345f9542dcaebff7b51f3bf5cc80f730b58ab759a58e574bea83fb793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Trials as Topic</topic><topic>Double-Blind Method</topic><topic>Drug Interactions</topic><topic>Female</topic><topic>Flurbiprofen - blood</topic><topic>Flurbiprofen - therapeutic use</topic><topic>Humans</topic><topic>Indomethacin - blood</topic><topic>Indomethacin - therapeutic use</topic><topic>Infant</topic><topic>Propionates - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rudge, SR</creatorcontrib><creatorcontrib>Lloyd‐Jones, JK</creatorcontrib><creatorcontrib>Hind, ID</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rudge, SR</au><au>Lloyd‐Jones, JK</au><au>Hind, ID</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between flurbiprofen and indomethacin in rheumatoid arthritis</atitle><jtitle>British journal of clinical pharmacology</jtitle><addtitle>Br J Clin Pharmacol</addtitle><date>1982-03</date><risdate>1982</risdate><volume>13</volume><issue>3</issue><spage>448</spage><epage>451</epage><pages>448-451</pages><issn>0306-5251</issn><eissn>1365-2125</eissn><abstract>The aim of this study was to measure serum levels of flurbiprofen and indomethacin when administered alone or in combination. Changes in clinical effect and toxicity were also noted. Ten patients with classical or definite rheumatoid arthritis (RA) according to the American Rheumatism Association's criteria agreed to take part in the study, which was approved by the Hospital Ethical Committee. All were female with ages ranging from 29-64 years (median 55 years) and a disease duration from 6 months-22 years (median 5 years).</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7037032</pmid><doi>10.1111/j.1365-2125.1982.tb01401.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0306-5251 |
| ispartof | British journal of clinical pharmacology, 1982-03, Vol.13 (3), p.448-451 |
| issn | 0306-5251 1365-2125 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1402125 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adolescent Adult Arthritis, Rheumatoid - drug therapy Child Child, Preschool Clinical Trials as Topic Double-Blind Method Drug Interactions Female Flurbiprofen - blood Flurbiprofen - therapeutic use Humans Indomethacin - blood Indomethacin - therapeutic use Infant Propionates - therapeutic use |
| title | Interaction between flurbiprofen and indomethacin in rheumatoid arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20flurbiprofen%20and%20indomethacin%20in%20rheumatoid%20arthritis&rft.jtitle=British%20journal%20of%20clinical%20pharmacology&rft.au=Rudge,%20SR&rft.date=1982-03&rft.volume=13&rft.issue=3&rft.spage=448&rft.epage=451&rft.pages=448-451&rft.issn=0306-5251&rft.eissn=1365-2125&rft_id=info:doi/10.1111/j.1365-2125.1982.tb01401.x&rft_dat=%3Cproquest_pubme%3E15510393%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15510393&rft_id=info:pmid/7037032&rfr_iscdi=true |